As of 2024-12-14, the EV/EBITDA ratio of Spago Nanomedical AB (publ) (SPAGO.ST) is -0.41. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. SPAGO.ST's latest enterprise value is 13.93 mil SEK. SPAGO.ST's TTM EBITDA according to its financial statements is -33.74 mil SEK. Dividing these 2 quantities gives us the above SPAGO.ST EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 17.2x - 24.9x | 19.9x |
| Forward P/E multiples | 17.5x - 24.4x | 19.1x |
| Fair Price | (1.56) - (2.23) | (1.75) |
| Upside | -982.8% - -1359.4% | -1090.1% |
| Date | EV/EBITDA |
| 2024-11-18 | -0.62 |
| 2024-11-15 | -0.75 |
| 2024-11-14 | -0.60 |
| 2024-11-13 | -0.64 |
| 2024-11-12 | -0.59 |
| 2024-11-11 | -0.65 |
| 2024-11-08 | -0.77 |
| 2024-11-07 | -0.61 |
| 2024-11-06 | -0.65 |
| 2024-11-05 | -0.65 |
| 2024-11-04 | -0.86 |
| 2024-11-01 | -0.75 |
| 2024-10-31 | -0.82 |
| 2024-10-30 | -0.82 |
| 2024-10-29 | -0.77 |
| 2024-10-28 | -0.69 |
| 2024-10-25 | -0.77 |
| 2024-10-24 | -0.86 |
| 2024-10-23 | -0.88 |
| 2024-10-22 | -0.86 |
| 2024-10-21 | -0.69 |
| 2024-10-18 | -0.92 |
| 2024-10-17 | -0.86 |
| 2024-10-16 | -0.96 |
| 2024-10-15 | -0.98 |
| 2024-10-14 | -0.90 |
| 2024-10-11 | -0.98 |
| 2024-10-10 | -0.96 |
| 2024-10-09 | -1.04 |
| 2024-10-08 | -1.04 |
| 2024-10-07 | -0.98 |
| 2024-10-04 | -0.96 |
| 2024-10-03 | -1.00 |
| 2024-10-02 | -0.88 |
| 2024-10-01 | -0.88 |
| 2024-09-30 | -0.88 |
| 2024-09-27 | -1.15 |
| 2024-09-26 | -1.06 |
| 2024-09-25 | -0.94 |
| 2024-09-24 | -1.25 |
| 2024-09-23 | -0.98 |
| 2024-09-20 | -0.98 |
| 2024-09-19 | -0.96 |
| 2024-09-18 | -0.65 |
| 2024-09-17 | -0.75 |
| 2024-09-16 | -0.77 |
| 2024-09-13 | -0.92 |
| 2024-09-12 | -1.12 |
| 2024-09-11 | -1.33 |
| 2024-09-10 | -1.37 |